The Bundeskartellamt has given the green light for the participation of full-line pharmaceutical wholesalers in the “VCI Emergency Platform for Vaccination Equipment.” The platform was launched with the Bundeskartellamt’s approval to better coordinate the supply of vaccination equipment (syringes, cannulas, and NaCI solution).
According to federal government plans, the pharmaceutical wholesale industry is to take control, together with the pharmacies, of the supply of the COVID-19 vaccine to physicians from the second quarter of 2021. This will also involve the provision of complete sets of vaccine and the necessary vaccination equipment.
Andreas Mundt, President of the Bundeskartellamt, said, “As the availability of vaccines will hopefully increase soon, their distribution will have to be optimised. This calls for close cooperation between different companies and public bodies. We already sent out a swift and unbureaucratic signal in February for the cooperation within the context of the ‘Emergency Platform for Vaccination Equipment.’ In our view it is therefore appropriate to open up the platform to the pharmaceutical wholesale industry. This sector can play an important role in distributing the vaccine and putting together vaccine sets. All in all it is assumed that the supply situation will improve with the help of the platform and the involvement of all the relevant market players. The platform’s duration is to be limited to the pandemic emergency situation.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Nominates Olivia Trusty for FCC Commissioner Role Ahead of Inauguration
Jan 16, 2025 by
CPI
Lawyers Claim eXp’s Settlement Tactics Hurt Antitrust Case Potential
Jan 16, 2025 by
CPI
Amex GBT Pushes Back Against DOJ Lawsuit Over CWT Acquisition
Jan 16, 2025 by
CPI
Belgium Opens Antitrust Probe into AB InBev’s Market Practices
Jan 16, 2025 by
CPI
Tech Groups Sue CFPB Over New Rule on Digital Wallet Oversight
Jan 16, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand